|4Oct 21, 12:05 PM ET

Agrawal Shantanu 4

4 · Performant Healthcare Inc · Filed Oct 21, 2025

Insider Transaction Report

Form 4
Period: 2025-10-21
Transactions
  • Disposition to Issuer

    Common Stock

    2025-10-2144,4300 total
  • Disposition to Issuer

    Restricted Stock Units

    2025-10-21$7.75/sh35,616$276,0240 total
    Common Stock (35,616 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2025-10-21$7.75/sh25,251$195,6950 total
    Common Stock (25,251 underlying)
Footnotes (4)
  • [F1]Pursuant to the Agreement and Plan of Merger, dated July 31, 2025 (the "Merger Agreement"), by and among Performant Healthcare, Inc. ("Performant" or "Company"), Continental Buyer, Inc., a Delaware corporation ("Continental" or "Parent") and Prevail Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Continental ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Performant, with Performant surviving the merger as a wholly-owned subsidiary of Continental (the "Merger").
  • [F2]Effective as of immediately prior to the Effective Time (as defined in the Merger Agreement), each share of the Company's Common Stock, par value $0.0001 per share, as the "Common Stock" or "Company Shares" issued and outstanding immediately prior to the Effective Time was canceled and converted into the right to receive $7.75 in cash without interest (the "Merger Consideration") subject to any applicable withholding taxes as provided in the Merger Agreement.
  • [F3]Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to time-based vesting restrictions, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant RSU") will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration.
  • [F4]All equity awards under the terms of the Company's Amended and Restated 2012 Stock Incentive Plan expire on the tenth anniversary of the original grant date.

Documents

1 file
  • 4
    wk-form4_1761062705.xmlPrimary

    FORM 4